BeStock  
Stocks › Biotechnology › TLX

Telix Pharmaceuticals TLX

US equityMarket cap rank #2480Biotechnology
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–

TLX Stock News

Headlines matching Telix Pharmaceuticals or the TLX ticker, most recent first.

  • H.C. Wainwright Maintains Telix Pharmaceuticals(TLX.US) With Buy Rating, Maintains Target Price $20Market news · 30 Sep 2026 · Direct mention
  • H.C. Wainwright Initiates Telix Pharmaceuticals(TLX.US) With Buy Rating, Announces Target Price $20Market news · 25 Sep 2026 · Direct mention
  • William Blair Initiates Telix Pharmaceuticals(TLX.US) With Buy RatingMarket news · 23 Sep 2026 · Direct mention
  • Telix Pharmaceuticals Raised to Buy From Hold by Bell Potter TLX.AU PositiveDow Jones · 15 Sep 2026 · Direct mention
  • Telix: Mark Nelson Will Continue to Serve on the Bd as a Non-Executive Director, Having Served as Interim Chair TLX.AX.AUDow Jones · 1 Sep 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TLX.

Sign in to join the discussion.

Scroll to Top